U.S. Consumer Durables Stock News

Netflix FY 2025 Results in Focus Netflix (NFLX) has capped FY 2025 with fourth quarter revenue of US$12.1 billion and basic EPS of US$0.57, alongside trailing twelve month revenue of US$45.2 billion and basic EPS of US$2.58 that frame the latest numbers in a broader run of profitability. The company has seen quarterly revenue move from US$10.2 billion and basic EPS of US$0.44 in Q4 2024 to US$12.1 billion and US$0.57 in Q4 2025, while trailing net profit margins have been described at 24.3%...

Everus Construction Group (ECG) is back in focus after third quarter 2025 earnings came in well ahead of analyst expectations, with EPS 52.05% higher and revenue 30% above the prior year. See our latest analysis for Everus Construction Group. The strong third quarter update comes after a mixed few months in the market, with a small 1.25% 1 month share price return and a 2.29% year to date share price gain. The 1 year total shareholder return of 18.84% points to momentum that has been building...

In late January 2026, U-Haul highlighted safety guidance around propane heaters and generators as a major winter storm was set to impact much of the U.S., drawing attention to its role as the largest U.S. propane retailer with more than 1,500 refill and tank exchange locations. Separately, U-Haul announced plans to release its third quarter fiscal 2026 results and host an investor call in early February, underscoring the growing importance of its propane operations alongside its core moving...

Earlier this week, Insperity shares moved after President Trump suspended planned tariffs on European allies, easing immediate concerns about a transatlantic trade conflict and supporting broader market sentiment. The reaction highlights how macro policy shifts can temporarily boost confidence in companies like Insperity, even as they contend with slower revenue growth and rising benefits costs. We’ll now examine how relief over suspended European tariffs, alongside rising benefits costs,...

Why Penumbra Is On Investors’ Radar Right Now Penumbra (PEN) has recently caught attention after a period of strong share price moves, with the stock showing double digit returns over the past month and past 3 months. See our latest analysis for Penumbra. That recent surge fits into a wider upswing, with a 16.11% year to date share price return and a 31.09% total shareholder return over the past year suggesting momentum has been building rather than fading. If Penumbra has you rethinking your...

StepStone Group's real estate arm, together with Blue Moon Capital Partners, closed a $250 million continuation vehicle focused on senior housing communities. The partners intend to use the vehicle to acquire additional senior housing properties over time. StepStone Group (NasdaqGS:STEP) is expanding its presence in senior housing, a niche within real estate that is closely tied to demographic trends such as aging populations. For you as an investor, this move sits at the intersection of...

Why Albany International’s new cybersecurity certification matters Albany International (AIN) just cleared a key hurdle for its Albany Engineered Composites segment, securing U.S. Department of War Cybersecurity Maturity Model Certification Level 2 through an accredited third party assessor. See our latest analysis for Albany International. The CMMC Level 2 certification lands at a time when Albany International’s share price has been relatively choppy, with a recent 1 month share price...

Cleveland-Cliffs (NYSE:CLF) signed a memorandum of understanding with POSCO, setting the stage for a new partnership around operations and potential balance sheet benefits. The company also appointed Edilson Camara to its Board of Directors, adding fresh leadership experience to its governance structure. These developments arrive as investors assess Cleveland-Cliffs’ recent share performance and its positioning in the steel and mining space. Cleveland-Cliffs, trading at $15.09, has seen...

Ames National (ATLO) has just wrapped up FY 2025 with fourth quarter revenue of US$19.3 million and EPS of US$0.73, capping a trailing twelve month run of US$65.8 million in revenue and EPS of US$2.14 that coincides with 86.2% earnings growth and a net profit margin of 28.9% over the last year. The company has seen revenue move from US$53.5 million and EPS of US$1.14 on a trailing basis at the end of 2024 to the latest trailing totals, which may help provide a clearer picture of earnings...

Perrigo, a major holding in the Invesco High Yield Dividend ETF (PEY), has recently come under scrutiny as it pays out more in dividends than it earns, reflecting pressures from weaker business performance. This mismatch between earnings and dividends raises a material question for income-focused investors: how reliable is Perrigo’s payout policy over time? We’ll now examine how concerns about Perrigo’s dividend sustainability shape its broader investment narrative for current and...

Gold Resource (GORO) is back in focus after a temporary work stoppage at its Don David mine in Oaxaca, driven by an illegal access blockade linked to a dispute among contractor affiliated union factions. See our latest analysis for Gold Resource. The recent contractor blockade comes after a period of strong share price momentum, with a 90 day share price return of 115.85% and a 1 year total shareholder return of 234.72%. However, the 5 year total shareholder return of a 40.59% decline shows...

In recent weeks, Williams-Sonoma has drawn heightened investor attention as analysts highlight its consistent earnings outperformance and resilient operations, even with expectations for a year-over-year earnings dip in the upcoming Q4 2025 report. An interesting angle is how the company’s disciplined capital returns and premium omnichannel home furnishings focus are shaping a cautiously bullish analyst stance. We’ll now examine how this focus on consistent earnings execution and capital...

PROCEPT BioRobotics has drawn increased attention for its AquaBeam Robotic System for benign prostatic hyperplasia, as investors react to past and upcoming regulatory and clinical milestones that were seen as potentially meaningful for the technology’s medical adoption prospects. An interesting angle is how options trading around these anticipated approvals and trial readouts has become a focal point for investors seeking to position around milestone-driven volatility. We’ll now examine how...

Recent performance snapshot OGE Energy (OGE) has moved quietly on the screens recently, with the stock slipping about 1.1% over the past day and 2.2% over the past week, keeping interest on its underlying fundamentals. Over the past month the share price has been broadly flat, while the past 3 months show an 8.2% decline. This backdrop may prompt you to compare recent returns with the company’s longer term profile. See our latest analysis for OGE Energy. Looking beyond the latest moves, OGE...

Setting the Scene for Huron Consulting Group Stock Huron Consulting Group (HURN) has drawn investor attention after a period of mixed short term returns, with the share price lower over the past week and month but higher over the past 3 months and year. See our latest analysis for Huron Consulting Group. Short term momentum has cooled, with a 7 day share price return of 6.61% and a 30 day share price return of 5.16%, but the 1 year total shareholder return of 37% and 5 year total shareholder...

Affinity Bancshares (AFBI) has reported solid headline numbers for FY 2025 so far, with third quarter total revenue of US$8.3 million and basic EPS of US$0.35, supported by trailing twelve month revenue of US$31.8 million and EPS of US$1.19. Across the last few reported quarters, revenue has moved from US$7.4 million in Q4 2024 to US$7.8 million in Q1 2025, US$8.3 million in Q2 2025 and US$8.3 million in Q3 2025. Over the same stretch, quarterly EPS has gone from US$0.21 to US$0.29, US$0.34...

After Herbalife's sharp share price moves, you might be wondering whether the current price offers value or if you are turning up late to the story. The stock recently closed at US$16.64, with a 1.9% decline over the last 7 days, a 24.8% gain over 30 days, a 29.8% gain year to date, and a 158.0% gain over the past year, set against longer term 3 year and 5 year returns of 3.4% decline and 67.3% decline respectively. Recent company news has focused on Herbalife's ongoing business performance...

SEALSQ Corp and WISeKey’s subsidiary recently signed a non-binding Memorandum of Understanding with the Government of Gujarat and Kaynes SemiCon to collaborate on establishing India’s first secure semiconductor design, test, and personalization center focused on post-quantum cryptography at Sanand, targeting capacity of up to 300 million secure chips annually. This planned joint venture, SEALKAYNESQ Ltd, is intended to support India’s onshore, quantum‑resistant semiconductor ecosystem for...

DigitalBridge Group (NYSE:DBRG) has agreed to be acquired by SoftBank for a cash consideration. The deal has triggered third party investigations into whether shareholders are receiving adequate compensation. Questions have also been raised about disclosures around the transaction and the absence of competing bids. DigitalBridge Group focuses on digital infrastructure assets, an area that sits at the intersection of data centers, networking and communications. The decision by SoftBank to...

If you are wondering whether FTAI Aviation's current share price lines up with its fundamentals, you are not alone. Many investors are asking the same question right now. The stock last closed at US$292.10, with returns of 6.7% over 7 days, 67.7% over 30 days, 38.9% year to date and 224.2% over 1 year, with the 3 year and 5 year returns both very large. Recent coverage around FTAI Aviation has focused on how its business model fits into broader themes in the aviation and leasing industry, as...

Revolution Medicines (NasdaqGS:RVMD) has attracted reported takeover interest from Merck, drawing fresh attention to the company and its pipeline. The interest surfaces as Revolution Medicines insiders, including General Counsel Jeff Cislini, have recently sold shares. Investors are weighing potential M&A activity alongside insider transactions and a sharply higher share price. Revolution Medicines enters this phase with strong recent share price moves, with the stock at $117.63 and up...

If you are wondering whether Dycom Industries is still good value after a strong run, this breakdown will help you see how the current price stacks up against different valuation yardsticks. The stock recently closed at US$368.21, with a 7 day return of a 0.6% decline, a 30 day return of 5.9%, and a 1 year return of 90.9%. The 3 year return is very large and the 5 year return is also very large. Recent news around Dycom Industries has focused on its role as a key contractor in U.S...

In recent weeks, Progyny received a series of analyst upgrades after meetings with management highlighted strong demand for its fertility benefits platform, improved earnings visibility, and nearly complete client retention heading into 2026. Analysts also emphasized Progyny’s breadth of over 600 employer clients and the absence of any single customer contributing more than 5% of revenue, underlining the resilience of its business model. Next, we’ll examine how this combination of...

Institutional investor commentaries highlight shifting sentiment on Doximity (NYSE:DOCS) following its latest quarterly results and outlook. The stock has faced pressure after cautious company guidance and recent healthcare policy changes. Hedge fund ownership has modestly increased, pointing to continued institutional interest despite recent share price moves. Doximity continues to focus on physician engagement, telehealth, and workflow tools as it responds to a rapidly changing digital...